Application of Photon Therapy Instrument Combined With Ultrasonic Debridement in Senile Third and Fourth Stage Pressure Injuries
Dahua Hospital, Xuhui District, Shanghai
1 other identifier
interventional
118
1 country
1
Brief Summary
These findings support the integrated use of ultrasonic debridement and photon therapy as a beneficial treatment strategy for advanced pressure injuries in elderly patients, demonstrating its value in improving both clinical results and overall patient well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 26, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedFebruary 3, 2026
May 1, 2023
1.2 years
January 26, 2026
January 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of Participants with Complete Wound Healing
The primary outcome is the proportion of participants achieving complete wound healing, defined as a Pressure Ulcer Scale for Healing (PUSH) score of 0. The PUSH tool assesses wound area, exudate amount, and tissue type, with a total score range of 0-17.
Assessed at 6 months post-randomization.
Secondary Outcomes (3)
Change in Pain Intensity During Dressing Changes
Baseline and 1 month post-intervention.
Total Direct Medical Cost of Treatment
From randomization to 6 months post-intervention.
Change in Wound Severity as Measured by the Pressure Ulcer Scale for Healing (PUSH) Score
Baseline, 1 month, 3 months, and 6 months post-intervention.
Other Outcomes (1)
Complete Healing Rate Stratified by Pressure Injury Stage
3 months and 6 months post-intervention.
Study Arms (2)
Photon Therapy Combined with Ultrasonic Debridement Group
OTHERParticipants in this arm received the combined intervention of ultrasonic debridement followed by photon therapy in addition to standard moist wound care and systemic management. Ultrasonic debridement was performed using a handheld device held at a 45-degree angle approximately 0.5 cm from the wound surface to selectively remove necrotic tissue. Subsequently, photon therapy was administered with the light source positioned 10 cm from the wound for 15 minutes per session, using blue light (for infected wounds) followed by red light as indicated. This combined physical therapy regimen aimed to enhance wound bed preparation, reduce bacterial load, promote tissue repair, and accelerate healing in elderly patients with stage 3 or 4 pressure injuries.
Standard Wound Care Grou
OTHERParticipants in this arm received standard moist wound care guided by the TIME principle (Tissue management, Infection/inflammation control, Moisture balance, and Edge advancement) and systemic interventions. Wounds were cleansed with 0.9% normal saline, and appropriate dressings were selected based on wound stage and exudate level. Dressing change frequency was determined according to clinical need. Systemic factors affecting wound healing were addressed, and comprehensive health education was provided, including guidance on repositioning, nutrition, and home care. This arm served as the control to evaluate the added benefit of the combined physical therapy intervention.
Interventions
Participants in this arm received the combined intervention of ultrasonic debridement followed by photon therapy in addition to standard moist wound care and systemic management. Ultrasonic debridement was performed using a handheld device held at a 45-degree angle approximately 0.5 cm from the wound surface to selectively remove necrotic tissue. Subsequently, photon therapy was administered with the light source positioned 10 cm from the wound for 15 minutes per session, using blue light (for infected wounds) followed by red light as indicated. This combined physical therapy regimen aimed to enhance wound bed preparation, reduce bacterial load, promote tissue repair, and accelerate healing in elderly patients with stage 3 or 4 pressure injuries.
Participants in this arm received standard moist wound care guided by the TIME principle (Tissue management, Infection/inflammation control, Moisture balance, and Edge advancement) and systemic interventions. Wounds were cleansed with 0.9% normal saline, and appropriate dressings were selected based on wound stage and exudate level. Dressing change frequency was determined according to clinical need. Systemic factors affecting wound healing were addressed, and comprehensive health education was provided, including guidance on repositioning, nutrition, and home care. This arm served as the control to evaluate the added benefit of the combined physical therapy intervention.
Eligibility Criteria
You may qualify if:
- age 55 years or older
- a patient who is fully conscious (i.e., no disturbance of consciousness such as drowsiness, lethargy, or delirium; able to accurately answer questions about time, place, and person orientation; and capable of clear communication to express needs or understand study-related instructions)
- patients with pressure injury were diagnosed with stage 3 or 4 pressure injury in accordance with the staging criteria of pressure injury published by the National Pressure Injury Advisory Panel (NPUAP).
You may not qualify if:
- poor blood glucose control (HbA1c \> 7.0%)
- patients allergic to red-and-blue light
- mental abnormalities who cannot cooperate with treatment
- patients with advanced malignancies, terminal patients, patients with cachexia, and patients with severe obesity
- severe complications: severe malnutrition, severe diseases of the lungs, liver, kidneys, and cardiovascular system
- patients undergoing other treatments, such as Chinese medicine treatment, negative pressure aspiration therapy, platelet-rich therapy
- who were unwilling to participate in the study. All participants signed a written informed consent form before the study began.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dahua Hospital, Xuhui District, Shanghai
Shanghai, Shanghai Municipality, 200031, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dahua Hospital, Xuhui District, Shanghai
Study Record Dates
First Submitted
January 26, 2026
First Posted
February 3, 2026
Study Start
May 1, 2023
Primary Completion
July 30, 2024
Study Completion
November 30, 2024
Last Updated
February 3, 2026
Record last verified: 2023-05